Sung Ji Nam

Stock Analyst at Scotiabank

(2.01)
# 2,995
Out of 4,911 analysts
82
Total ratings
41.18%
Success rate
-7.92%
Average return

Stocks Rated by Sung Ji Nam

Bio-Techne
Jul 11, 2025
Maintains: Sector Outperform
Price Target: $90$75
Current: $58.47
Upside: +28.27%
Danaher
Jul 11, 2025
Upgrades: Sector Outperform
Price Target: $275
Current: $202.81
Upside: +35.59%
Thermo Fisher Scientific
Jul 11, 2025
Upgrades: Sector Outperform
Price Target: $590
Current: $475.03
Upside: +24.20%
Illumina
Jul 11, 2025
Downgrades: Sector Perform
Price Target: $125
Current: $107.64
Upside: +16.13%
Castle Biosciences
May 21, 2025
Maintains: Sector Outperform
Price Target: $44$40
Current: $16.43
Upside: +143.46%
Biodesix
May 21, 2025
Maintains: Sector Outperform
Price Target: $3$2
Current: $0.42
Upside: +378.81%
Myriad Genetics
May 21, 2025
Downgrades: Sector Perform
Price Target: $20$6
Current: $4.65
Upside: +29.03%
Guardant Health
May 5, 2025
Maintains: Sector Outperform
Price Target: $52$57
Current: $45.49
Upside: +25.30%
Bionano Genomics
Apr 2, 2025
Maintains: Sector Perform
Price Target: $1$4
Current: $3.46
Upside: +15.61%
Pacific Biosciences of California
Mar 25, 2025
Maintains: Sector Outperform
Price Target: $6$2
Current: $1.54
Upside: +29.87%
Maintains: Sector Outperform
Price Target: $70$73
Current: $48.77
Upside: +49.68%
Maintains: Sector Outperform
Price Target: $10$12
Current: $10.66
Upside: +12.57%
Upgrades: Sector Outperform
Price Target: $430$450
Current: $298.47
Upside: +50.77%
Maintains: Sector Outperform
Price Target: $54$62
Current: $35.08
Upside: +76.74%
Maintains: Sector Outperform
Price Target: $40$44
Current: $23.59
Upside: +86.52%
Maintains: Buy
Price Target: $40$35
Current: $12.84
Upside: +172.59%
Assumes: Buy
Price Target: $6
Current: $5.17
Upside: +16.05%
Downgrades: Neutral
Price Target: n/a
Current: $18.41
Upside: -